Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Rubius Therapeutics, Inc. | 25,000 | reported | 12 May 2022 | tx 6+150,000 |
| Innocoll Holdings plc | 0 | reported | 24 Jul 2017 | tx 3−558,642 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 May 2022 | GRANT_AWARD | Rubius Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 12 May 2021 | GRANT_AWARD | Rubius Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 21 May 2020 | GRANT_AWARD | Rubius Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 23 May 2019 | GRANT_AWARD | Rubius Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 20 Jul 2018 | PURCHASE | Rubius Therapeutics, Inc. | 25,000 | 23.00 USD | |
| 17 Jul 2018 | GRANT_AWARD | Rubius Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 24 Jul 2017 | OTHER | Innocoll Holdings plc | 525,446 | — | |
| 24 Jul 2017 | OTHER | Innocoll Holdings plc | 14,907 | — | deriv |
| 24 Jul 2017 | OTHER | Innocoll Holdings plc | 18,289 | — | deriv |